References
- Dain J. G., Bhuta S. I., Coombs R. A., Talbot K. C., Dugger H. A. Metabolism of butalbital, 5-allyl-5-isobutylbarbituric acid, in the dog. Drug Metabolism and Disposition 1980; 8: 247–252
- Doddrell D. M. D. T., Bendall M. R. Distortionless enhancement of NMR signals by polarization transfer. Journal of Magnetic Resonance 1982; 48: 323–327
- Gibaldi M., Boyes R. N., Feldman S. Influence of first-pass effect on availability of drugs on oral administration. Journal of Pharmaceutical Sciences 1971; 60: 1338–1340
- Guyton A. C. Basic Human Physiology: Normal Function and Mechanisms of Disease. W. B. Saunders, Philadelphia 1971; 330
- Hanson R. L., Isaacson C. M. Stimulation of insulin secretion from isolated rat islets by SaRI 59–801. Relation to cAMP concentration and Ca2+ uptake. Diabetes 1985; 34: 691–695
- Hanson R. L., Isaacson C. M., Boyajy L. D. Stimulation of insulin secretion from isolated rat islets by SaRi 59–801. Diabetes 1985; 34: 548–552
- Ho R. S., Wiseherg J. J., Brand L. J., Nadelson J., Boyajy L. D. A novel, orally effective hypoglycemic agent, SaRI 59–801, in laboratory animals. Drug Development Research 1985; 6: 67–77
- Schwarz H. J. Pharmacokinetics of pindolol in humans and several animal species. American Heart Journal 1982; 104: 357–364
- Toothaker R. D., Welling P. G. Effect of dose size on the pharmacokinetics of intravenous hydrocortisone during endogenous hydrocortisone suppression. Journal of Pharmacokinetics and Biopharmaceutics 1982; 10: 147–156
- Tse F. L. S., Orwig B. A., Chang T., Guarducci L., Jaffe J. M. Effect of age on the disposition of α-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-3-indole-methanol in the rat. Drugs under Experimental and Clinical Research 1984; 10: 225–234
- Tse F. L. S., Orwig B., Jaffe J. M. Disposition of α-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)-1H-indole-3-methanol (59–801), a hypoglycemic agent, in rats, dogs and monkeys. Xenobiotica 1987; 17: 741–749